Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Drospirenone

A synthetic progestogen derived from spironolactone, patented in 1976 and introduced in 2000 in a contraceptive pill together with ethinylestradiol; it is also used in menopausal hormone therapy. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Apart from natural progesterone, it is the only progestogen in clinical use with marked antimineralocorticoid activity, like the diuretic spironolactone it derives from.

DrospirenoneGo to the active ingredient →
DrospirenoneActive ingredientDrospirenoneCat. No. P-D191-001CAS 67392-87-4

EDQM standards 2

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.